TrialNagoya journal of medical science2021

Phase Ib study on the humanized anti-CCR4 antibody, KW-0761, in advanced solid tumors.

Takuro Saito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.